Management of invasive squamous cell carcinomas of the conjunctiva Treatment of invasive conjunctival carcinoma

Ocular Oncology

PD-L1 and PD-L2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications

Am J Ophthalmol.

Wolkow N, Jakobiec FA, Afrogheh AH, Eagle RC Jr, Pai SI, Faquin WC

doi: 10.1016/j.ajo.2018.12.020.

Report on the incidence of squamous cell carcinomas affecting the eyelids in England over a 15-year period (2000-2014)

Br J Ophthalmol.

Wawrzynski J, Tudge I, Fitzgerald E, Collin R, Desai P, Emeriewen K, Saleh GM

doi: 10.1136/

Ocular Oncology

Efficacy of Vismodegib for the Treatment of Orbital and Advanced Periocular Basal Cell Carcinoma

Am J Ophthalmol.

Eiger-Moscovich M, Reich E, Tauber G, Berliner O, Priel A, Ben Simon G, Elkader AA, Yassur I

doi: 10.1016/j.ajo.2019.04.013.

Randomized, controlled, crossover trial comparing the impact of sham or intranasal neurostimulation on conjunctival goblet cell degranulation

Am J Ophthalmol.

Gumus K, Schuetzle KL, Pflugfelder SC

doi: 10.1016/j.ajo.2017.03.002.

Ocular Oncology

Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia

Clin Exp Ophthalmol.

Polski A, Sibug Saber M, Kim JW, Berry JL

doi: 10.1111/ceo.13382.

Further Publications

ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion

Retina.

Rizzo S, Barale PO, Ayello-Scheer S, Devenyi RG, Delyfer MN, Korobelnik JF, Rachitskaya A, Yuan A, Jayasundera KT, Zacks DN, Handa JT, Montezuma SR, Koozekanani D, Stanga PE, da Cruz L, Walter P, Augustin AJ, Chizzolini M, Olmos de Koo LC, Ho AC, Kirchhof B, Hahn P, Vajzovic L, Iezzi R Jr, Gaucher D, Arevalo JF, Gregori NZ, Grisanti S, Özmert E, Yoon YH, Kokame GT, Lim JI, Szurman P, de Juan E Jr, Rezende FA, Salzmann J, Richard G, Huang SS, Merlini F, Patel U, Cruz C, Greenberg RJ, Justus S, Cinelli L, Humayun MS

doi: 10.1097/IAE.

Surgery and Intervention

Comparison of topical 5-fluorouracil and interferon alfa-2b as primary treatment modalities for ocular surface squamous neoplasia

Am J Ophthalmol.

Venkateswaran N, Mercado C, Galor A, Karp CL

doi: 10.1016/j.ajo.2018.11.007.

Macular DiseasesSurgery and Intervention

CHANGES OF AQUEOUS HUMOR MÜLLER CELLS' BIOMARKERS IN HUMAN PATIENTS AFFECTED BY DIABETIC MACULAR EDEMA AFTER SUBTHRESHOLD MICROPULSE LASER TREATMENT

Retina.

Midena E, Bini S, Martini F, Enrica C, Pilotto E, Micera A, Esposito G, Vujosevic S

doi: 10.1097/IAE.

Further Publications

Medical and surgical management of conjunctivochalasis

Ocul Surf.

Marmalidou A, Palioura S, Dana R, Kheirkhah A

doi: 10.1016/j.jtos.

Related content

PD-L1 and PD-L2 Are Expressed in Conjunctival Invasive Squamous Cell Carcinoma: Therapeutic Implications

Report on the incidence of squamous cell carcinomas affecting the eyelids in England over a 15-year period (2000-2014)

Efficacy of Vismodegib for the Treatment of Orbital and Advanced Periocular Basal Cell Carcinoma

Randomized, controlled, crossover trial comparing the impact of sham or intranasal neurostimulation on conjunctival goblet cell degranulation

Extending far and wide: the role of biopsy and staging in the management of ocular surface squamous neoplasia

ADVERSE EVENTS OF THE ARGUS II RETINAL PROSTHESIS: Incidence, Causes, and Best Practices for Managing and Preventing Conjunctival Erosion

Comparison of topical 5-fluorouracil and interferon alfa-2b as primary treatment modalities for ocular surface squamous neoplasia

CHANGES OF AQUEOUS HUMOR MÜLLER CELLS' BIOMARKERS IN HUMAN PATIENTS AFFECTED BY DIABETIC MACULAR EDEMA AFTER SUBTHRESHOLD MICROPULSE LASER TREATMENT

Medical and surgical management of conjunctivochalasis